Cancel
Jeffrey J. Fessler, J.D.
Acting General Counsel
@
Aridis Pharmaceuticals
u.n1nqqny.3.qw@z30nk998z83g.189
Sign up to see email
Known information
- Has more than 20 years of experience providing corporate and securities legal counsel in the biotechnology industry
- Has extensive experience providing counsel in public offerings and private placements as well as mergers and acquisitions, joint ventures, proxy contests, restructurings, and private equity and debt financings
- Is a partner in the Sheppard Mullin law firm
- Has practiced corporate and securities law at several large firms, including Akin, Gump, Strauss, Hauer & Feld and Orrick, Herrington & Sutcliffe, and Sichenzia Ross Friedman Ference LLP
- Holds a B.S. degree in Accounting from the University of Maryland
- Earned his J.D. (magna cum laude) from New York Law School
About Aridis Pharmaceuticals
Aridis Pharmaceuticals develops novel therapies for infectious diseases, focusing on monoclonal antibodies from convalescent patients, with a pipeline addressing hospital-acquired infections, cystic fibrosis, and COVID-19.
Report inaccurate information
